Cargando…
Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway
Renal fibrosis is a pathological characteristic of the endpoint of chronic kidney disease (CKD), which remains a major public health problem. None of the current therapies is effective in stopping kidney fibrosis progression. In light of our novel detection of a potential antifibrosis of microcystin...
Autores principales: | Ren, Yan, Wang, Jie, Guo, Wenwen, Chen, Jingwen, Wu, Xin, Gu, Shubo, Xu, Lizhi, Wu, Zhiwei, Wang, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218570/ https://www.ncbi.nlm.nih.gov/pubmed/35754468 http://dx.doi.org/10.3389/fphar.2022.830312 |
Ejemplares similares
-
Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
por: Wang, Jie, et al.
Publicado: (2021) -
Renoprotection against complete unilateral ureteric obstruction: Is there an ultimate choice?
por: Khalil, Khaled I., et al.
Publicado: (2012) -
Renoprotective Effects of Maslinic Acid on Experimental Renal Fibrosis in Unilateral Ureteral Obstruction Model via Targeting MyD88
por: Sun, Wenjuan, et al.
Publicado: (2021) -
Microcystin-RR is a biliary toxin selective for neonatal cholangiocytes
por: Gupta, Kapish, et al.
Publicado: (2023) -
Proteomic evidences for microcystin-RR-induced toxicological alterations in mice liver
por: Rai, Ashutosh Kumar, et al.
Publicado: (2018)